Ataluren/ivacaftor combination therapy: Two N‐of‐1 trials in cystic fibrosis patients with nonsense mutations-Reference-Cited by-同舟云学术

Ataluren/ivacaftor combination therapy: Two N‐of‐1 trials in cystic fibrosis patients with nonsense mutations

Author:

Peabody Lever Jacelyn E.¹²^ORCID,Mutyam Venkateshwar¹³,Hathorne Heather Y.¹³,Peng Ning³,Sharma Jyoti¹,Edwards Lloyd J.⁴,Rowe Steven M.¹²⁵^ORCID

Affiliation:

1. Department of MedicineUniversity of Alabama at BirminghamBirmingham Alabama

2. Department of MedicineMedical Scientist Training Program, University of Alabama at BirminghamBirmingham Alabama

3. Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at BirminghamBirmingham Alabama

4. Department of BiostatisticsUniversity of Alabama at BirminghamBirmingham Alabama

5. Department of MedicinePediatrics and Cell Developmental and Integrative Biology, University of Alabama at BirminghamBirmingham Alabama

Funder

Cystic Fibrosis Foundation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

Reference6 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献